We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$345M
AUM Growth
-$28.9M
Cap. Flow
-$37.9M
Cap. Flow %
-10.97%
Top 10 Hldgs %
29.4%
Holding
780
New
93
Increased
153
Reduced
203
Closed
29

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.68%
2 Technology 13.28%
3 Healthcare 12.33%
4 Financials 8.86%
5 Consumer Discretionary 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDN
276
Brandywine Realty Trust
BDN
$499M
$121K 0.03%
11,655
+11,449
+5,558% +$124K
HON icon
277
Honeywell
HON
$64.5B
$119K 0.03%
769
-190
-20% -$28.2K
META icon
278
Meta Platforms (Facebook)
META
$1.71T
$119K 0.03%
+453
New +$117K
ADC icon
279
Agree Realty
ADC
$8.72B
$119K 0.03%
+1,863
New +$123K
INCY icon
280
Incyte
INCY
$24.7B
$118K 0.03%
1,318
+194
+17% +$18.7K
TCF
281
DELISTED
TCF Financial Corporation Common Stock
TCF
$117K 0.03%
5,018
+3,581
+249% +$95.8K
CHCT
282
Community Healthcare Trust
CHCT
$420M
$117K 0.03%
+2,500
New +$114K
QRVO icon
283
Qorvo
QRVO
$10.4B
$117K 0.03%
906
-639
-41% -$79.2K
IRM icon
284
Iron Mountain
IRM
$33.4B
$116K 0.03%
4,336
+4,324
+36,033% +$123K
HIW icon
285
Highwoods Properties
HIW
$3.39B
$116K 0.03%
3,457
+202
+6% +$7.44K
AWF
286
AllianceBernstein Global High Income Fund
AWF
$856M
$115K 0.03%
+10,900
New +$116K
BCEL
287
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$113K 0.03%
8,068
+3,798
+89% +$56.6K
ITRI icon
288
Itron
ITRI
$4.04B
$111K 0.03%
+1,823
New +$116K
XLRN
289
DELISTED
Acceleron Pharma
XLRN
$110K 0.03%
+980
New +$97.6K
REGN icon
290
Regeneron Pharmaceuticals
REGN
$79.7B
$108K 0.03%
193
+192
+19,200% +$116K
CDTX
291
DELISTED
Cidara Therapeutics
CDTX
$102K 0.03%
1,793
-118
-6% -$8.33K
XEL icon
292
Xcel Energy
XEL
$45.3B
$102K 0.03%
1,477
+250
+20% +$17.1K
CGC
293
Canopy Growth
CGC
$389M
$102K 0.03%
711
MET icon
294
MetLife
MET
$62.4B
$101K 0.03%
2,728
-439
-14% -$16.7K
BA icon
295
Boeing
BA
$166B
$101K 0.03%
+611
New +$104K
PM icon
296
PUT
Philip Morris
PM
$303B
$98.7K 0.03%
+87
New +$6.71K
PHR icon
297
Phreesia
PHR
$642M
$98.6K 0.03%
+3,069
New +$91.4K
CCXI
298
DELISTED
ChemoCentryx, Inc.
CCXI
$98.3K 0.03%
1,794
+182
+11% +$9.8K
KBWB icon
299
Invesco KBW Bank ETF
KBWB
$6.74B
$96.3K 0.03%
+2,570
New +$99.5K
PHAT icon
300
Phathom Pharmaceuticals
PHAT
$660M
$96.3K 0.03%
2,627
-150
-5% -$5.2K

Similar funds

Exane Derivatives's Q3 2020 Portfolio in Review

As of Q3 2020, Exane Derivatives held 780 positions worth $345M, down 7.7% from $374M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Exane Derivatives withdrew a net $37.9M in Q3 2020, closing 29 positions and reducing 203 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $8.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 34% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in iShares MSCI Turkey ETF worth $10.6M.

  • Exane Derivatives's largest Q3 2020 buy was iShares MSCI Turkey ETF: 537,062 shares worth $10.6M.
  • Exane Derivatives added most to State Street Energy Select Sector SPDR ETF in Q3 2020, an estimated $15.1M increase.
  • Exane Derivatives's biggest Q3 2020 reduction was Linde, cutting an estimated $7.17M.
  • Exane Derivatives fully exited iShares MSCI Emerging Markets ETF in Q3 2020, selling an estimated $8.3M.
  • Exane Derivatives's ten largest holdings make up 29% of its $345M portfolio in Q3 2020.
  • Exane Derivatives opened 93 new positions and closed 29 in Q3 2020.
  • Exane Derivatives's portfolio value fell 7.7% quarter-over-quarter to $345M.

Based on Exane Derivatives's 13F filing for Q3 2020, filed 6 Oct 2020.